The main benefit of using the drug long-term is maintaining weight loss or regulating blood sugar
La mayora de los pacientes experimentan resultados ms significativos despus de alcanzar la dosis de mantenimiento de 2.4 mg, con prdida de peso mxima entre los 12 y 18 meses de tratamiento continuo
1 Introduction -1 antitrypsin (A1AT) (Alpha-1 Proteinase Inhibitor, 1-Pi) belongs to the serine protease inhibitor superfamily (SERPIN)
Several of the other Alzheimers candidates under development are symptom-reducing drugs that target specific cognitive, emotional, or behavioral symptoms of Alzheimers, with the aim of managing symptoms like agitation, loss of awareness, and sleep disturbances
It's important to talk to a doctor to figure out what's best for you
Metformin is the first-line glucose-lowering agent unless the patient has a moderate to severe decline in eGFR